Reducing Hallucinations and Streamlining Drug Discovery Workflows with Generative AI - with Asif Hasan of Quantiphi

Today's guest is Asif Hasan, Co-founder of Quantiphi. Quantiphi is an AI-first digital engineering company that designs AI-driven services and platforms for broad applications across industries. In conversation with Emerj CEO and Head of Research Daniel Faggella, Asif discusses reducing hallucinations in healthcare language models and the latest developments in AI's impact on drug discovery for rare disorders. If you've enjoyed or benefited from the insights in this episode, consider leaving us a five-star review on Apple Podcasts and let us know what you learned or liked most about this show or what you'd like to see in the future.